Literature DB >> 18184681

Obstructive sleep apnoea is associated with decreased insulin sensitivity in females.

J Theorell-Haglöw1, C Berne, C Janson, E Lindberg.   

Abstract

The aim of the present study was to assess associations between obstructive sleep apnoea and insulin sensitivity in a population-based sample of females. In total, 400 females aged 20-70 yrs underwent a full-night polysomnography, fasting blood sampling, measurement of anthropometric variables and oral glucose tolerance test with measurement of the insulin response (n = 358). The apnoea/hypopnoea index (AHI) was calculated from the results of the polysomnography. From the results of the oral glucose tolerance test, an insulin sensitivity index (ISI) was calculated. Females with an AHI < 5 (n = 119) had a mean+/-SD ISI of 8.3+/-3.8, whereas females with an AHI > or = 30 (n = 34) had an ISI of 6.2+/-4.0. Nocturnal minimal saturation was independently associated with decreased insulin sensitivity when controlling for age, waist/hip ratio, level of physical activity, smoking and alcohol consumption (95% confidence interval (CI) 0.004-0.14). When adjusting for confounders, the AHI was associated with increased fasting and 2-h insulin levels (95% CI 0.14-0.99 and 95% CI 0.28-6.47, respectively). Obstructive sleep apnoea was found to be independently associated with decreased insulin sensitivity in the present population-based sample of females.

Entities:  

Mesh:

Year:  2008        PMID: 18184681     DOI: 10.1183/09031936.00074907

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

Review 1.  Obstructive Sleep Apnoea and Type 2 Diabetes.

Authors:  Abd A Tahrani; Asad Ali
Journal:  Eur Endocrinol       Date:  2014-02-28

2.  Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up.

Authors:  Yelda Turgut Celen; Jan Hedner; Jan Carlson; Yüksel Peker
Journal:  J Clin Sleep Med       Date:  2010-06-15       Impact factor: 4.062

3.  Smoking induces oropharyngeal narrowing and increases the severity of obstructive sleep apnea syndrome.

Authors:  Kyung Soo Kim; Jun Hee Kim; Sung Yoon Park; Ho-Ryun Won; Hyun-Jin Lee; Hoon Shik Yang; Hyun Jik Kim
Journal:  J Clin Sleep Med       Date:  2012-08-15       Impact factor: 4.062

Review 4.  Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.

Authors:  Karl A Franklin; Eva Lindberg
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 5.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 6.  Sleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms.

Authors:  Michael A Grandner; Azizi Seixas; Safal Shetty; Sundeep Shenoy
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

7.  Epworth sleepiness scale scores and adverse pregnancy outcomes.

Authors:  Ghada Bourjeily; Rana El Sabbagh; Peter Sawan; Christina Raker; Carren Wang; Beth Hott; Mariam Louis
Journal:  Sleep Breath       Date:  2013-02-19       Impact factor: 2.816

8.  [One-hour post-load plasma glucose: a better indicator of glucose metabolism for obstructive sleep apnea?]

Authors:  Yuan Feng; Dong-Ying Guo; Miao Luo; Ting Xu; Dan-Qing Li; Ya-Hui Lei; Tao-Ping Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

9.  Mild obstructive sleep apnea increases hypertension risk, challenging traditional severity classification.

Authors:  Izolde Bouloukaki; Ludger Grote; Walter T McNicholas; Jan Hedner; Johan Verbraecken; Gianfranco Parati; Carolina Lombardi; Ozen K Basoglu; Athanasia Pataka; Oreste Marrone; Paschalis Steiropoulos; Marisa R Bonsignore; Sophia E Schiza
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

Review 10.  Do sleep disorders and associated treatments impact glucose metabolism?

Authors:  Naresh M Punjabi
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.